Some pretty big misses here due to lower production at Curragh
Q2 vs Q1
EBITDA: ~438m vs ~410m
ROM Prod: 5.5Mt vs 6.7Mt - miss on cons
Sales: 3.9Mt vs 4.4Mt - miss on cons
Group Price received (inc thermal) /t: 277 vs 228
Total costs ex D&A /t: 160 vs 129 - guidance increased
Net Cash: 171m vs 257m, after 351m div payment
Ann: Q2 Quarterly Activities Report, page-3
Add CRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.035(2.94%) |
Mkt cap ! $1.936B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.21 | $1.16 | $2.323M | 1.984M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 46587 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 72963 | 5 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| CRN (ASX) Chart |